Qian Qijun is the founder of Shanghai Cell Therapy Group. Shanghai Cell Therapy Group has raised $134M in total funding. Latest round: Series C.
Qian Qijun is the Chairman of Shanghai Cell Therapy Group, a company focused on the R&D of cellular immunotherapy technologies, cell banking services, and cancer treatment. He previously served as the Director of the Cancer Biotherapy Center at the Second Military Medical University and the Director of the Oncology Biotherapy Department at the Eastern Hepatobiliary Surgery Hospital.
Full founder directory · Investor directory · Company funding database · Fundraising library